Sonic Healthcare Limited (SKHCF)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Sonic Healthcare Limited (SKHCF) trades at $12.76. Sonic Healthcare Limited is a global medical diagnostics company providing laboratory and radiology services. Market cap: $6.31B, Sector: Healthcare.
Price live · AI analysis from Mar 15, 2026Analyst Coverage for SKHCF: SKHCF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates SKHCF against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
SKHCF: 1/1 perspectives are bearish.
How is this calculated? →Sonic Healthcare Limited (SKHCF) Healthcare & Pipeline Overview
Sonic Healthcare Limited is a global leader in medical diagnostics, offering comprehensive laboratory and radiology services across multiple countries. With a focus on pathology and imaging, the company serves medical practitioners, hospitals, and community health services, contributing to patient care through advanced diagnostic capabilities and a widespread operational network.
What Is the Investment Thesis for SKHCF?
Sonic Healthcare Limited presents a compelling investment case based on its established position in the medical diagnostics market and diverse service offerings. With a P/E ratio of 19.42 and a dividend yield of 5.09%, the company demonstrates financial stability. Growth catalysts include expanding its radiology and primary care services, leveraging its international presence, and capitalizing on the increasing demand for diagnostic testing. The company's beta of 0.54 suggests lower volatility compared to the market, potentially appealing to risk-averse investors. However, investors should monitor competitive pressures and regulatory changes in the healthcare sector, which could impact profitability. The company's ability to maintain its profit margin of 5.2% and gross margin of 29.6% will be crucial for sustained growth.
Based on FMP financials and quantitative analysis
SKHCF Key Highlights
- Market Cap of $6.31B reflects Sonic Healthcare's significant presence in the medical diagnostics industry.
- P/E Ratio of 19.42 indicates a reasonable valuation compared to its earnings.
- Dividend Yield of 5.09% provides an attractive income stream for investors.
- Gross Margin of 29.6% demonstrates the company's ability to manage its cost of goods sold effectively.
- Beta of 0.54 suggests lower volatility compared to the overall market, potentially appealing to risk-averse investors.
Who Are SKHCF's Competitors?
SKHCF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| CNVVF ConvaTec Group Plc | $2.73 | +0.00% | $5.32B | 49 |
| CNVVY ConvaTec Group Plc | $11.87 | +0.61% | $5.80B | 43 |
| DSRLF DiaSorin S.p.A. | $81.00 | +0.00% | $4.01B | 52 |
| GNGBY Getinge AB (publ) | $21.23 | -0.04% | $5.78B | 47 |
| KYKOF Kyowa Kirin Co., Ltd. | $14.43 | +0.00% | $7.55B | 57 |
| PRE Prenetics Global Limited | $16.71 | -4.48% | $284.02M | 69 |
| EPGNY Epigenomics AG | $2.39 | +0.00% | 68 | |
| STRRP Star Equity Holdings, Inc. | $9.99 | +1.01% | $42.56M | 68 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are SKHCF's Key Strengths?
- Comprehensive range of diagnostic services.
- Extensive international network.
- Strong relationships with healthcare providers.
- Reputation for high-quality services.
What Are SKHCF's Weaknesses?
- Dependence on healthcare regulations and reimbursement policies.
- Exposure to competition from other diagnostic service providers.
- Potential for errors in diagnostic testing.
- Vulnerability to economic downturns.
What Could Drive SKHCF Stock Higher?
- Expansion of laboratory and radiology services in existing markets.
- Development and adoption of new diagnostic technologies.
- Potential acquisitions of complementary businesses.
- Growth in demand for diagnostic testing due to aging population and increasing prevalence of chronic diseases.
- Strategic partnerships with healthcare providers and research institutions.
What Are the Key Risks for SKHCF?
- Changes in healthcare regulations and reimbursement policies could negatively impact revenue.
- Increased competition from other diagnostic service providers could erode market share.
- Technological obsolescence could render existing diagnostic equipment and services obsolete.
- Economic downturns could reduce demand for diagnostic testing.
- Errors in diagnostic testing could lead to liability claims and reputational damage.
What Are the Growth Opportunities for SKHCF?
- Expansion of Radiology Services: Sonic Healthcare can expand its radiology services by investing in advanced imaging technologies and expanding its network of radiology clinics. The global radiology market is projected to reach $36.3 billion by 2027, driven by increasing demand for diagnostic imaging. This expansion would allow Sonic Healthcare to capture a larger share of the radiology market and increase its revenue streams.
- Growth in Primary Care Services: Sonic Healthcare has the opportunity to grow its primary care medical services, including general practice clinics, occupational health services, and skin cancer clinics. The increasing demand for primary care services, driven by an aging population and a focus on preventive care, presents a significant growth opportunity. By expanding its primary care network, Sonic Healthcare can attract new patients and generate recurring revenue.
- International Expansion: Sonic Healthcare can further expand its international presence by entering new markets and expanding its operations in existing markets. The global medical diagnostics market is expected to grow significantly in emerging economies, presenting opportunities for Sonic Healthcare to expand its reach and diversify its revenue streams. This expansion would allow Sonic Healthcare to capitalize on the growing demand for diagnostic services in these markets.
- Technological Advancements: Sonic Healthcare can leverage technological advancements in diagnostic testing to improve its services and increase its efficiency. The development of new diagnostic technologies, such as molecular diagnostics and artificial intelligence-powered diagnostics, presents opportunities for Sonic Healthcare to offer more accurate and efficient testing services. By adopting these technologies, Sonic Healthcare can enhance its competitive advantage and attract new customers.
- Strategic Acquisitions: Sonic Healthcare can pursue strategic acquisitions to expand its service offerings and geographic reach. Acquiring complementary businesses, such as specialty diagnostic labs or radiology groups, would allow Sonic Healthcare to expand its capabilities and enter new markets. This strategy would enable Sonic Healthcare to accelerate its growth and strengthen its position in the medical diagnostics market.
What Opportunities Does SKHCF Have?
- Expansion into new geographic markets.
- Development of new diagnostic technologies.
- Strategic acquisitions of complementary businesses.
- Growth in demand for diagnostic testing due to aging population.
What Threats Does SKHCF Face?
- Changes in healthcare regulations and reimbursement policies.
- Increased competition from other diagnostic service providers.
- Technological obsolescence.
- Economic downturns.
What Are SKHCF's Competitive Advantages?
- Established network of laboratories and radiology clinics provides a wide geographic reach.
- Strong relationships with medical practitioners and hospitals ensure a steady stream of referrals.
- Reputation for high-quality diagnostic services builds trust with customers.
- Comprehensive range of diagnostic services offers a one-stop-shop solution for healthcare providers.
What Does SKHCF Do?
Sonic Healthcare Limited, established in 1934 and headquartered in Sydney, Australia, is a leading international medical diagnostics company. The company provides a broad spectrum of services, including laboratory medicine/pathology testing, encompassing biochemistry, cytopathology, genetics, haematology, histopathology, immunoserology, microbiology, molecular pathology, prenatal testing, and toxicology. Additionally, Sonic Healthcare offers comprehensive radiology services, such as magnetic resonance imaging (MRI), computed tomography (CT), ultrasound, X-ray, mammography, nuclear medicine, PET CT, interventional procedures, and bone mineral densitometry. Beyond diagnostics, Sonic Healthcare extends its offerings to primary care medical services, operating general practice clinics, occupational health services, skin cancer clinics, after-hours general practice services, general practice IT solutions, and community-based healthcare services. The company's global footprint spans across Australia, the United Kingdom, Ireland, the United States, Germany, Switzerland, New Zealand, and Belgium, reflecting its extensive network and international presence. Sonic Healthcare's integrated approach to diagnostics and primary care positions it as a key player in the healthcare ecosystem, serving medical practitioners, hospitals, community health services, and their patients with comprehensive and advanced medical solutions.
What Products and Services Does SKHCF Offer?
- Provides laboratory medicine and pathology testing services.
- Offers radiology services including MRI, CT scans, and X-rays.
- Operates general practice clinics and occupational health services.
- Provides skin cancer clinics and after-hours general practice services.
- Offers general practice IT solutions.
- Delivers community-based healthcare services.
- Conducts prenatal testing and toxicology services.
How Does SKHCF Make Money?
- Generates revenue through laboratory testing services provided to medical practitioners and hospitals.
- Earns income from radiology services, including diagnostic imaging and interventional procedures.
- Receives payments for primary care medical services provided in its clinics.
- Derives revenue from occupational health services and skin cancer clinics.
What Industry Does SKHCF Operate In?
Sonic Healthcare operates within the growing medical diagnostics and research industry. The industry is driven by an aging population, increasing prevalence of chronic diseases, and technological advancements in diagnostic tools. The competitive landscape includes companies like CNVVF (Clover Health Investments Corp), CNVVY (Clover Health Investments Corp), DSRLF (Dare Bioscience Inc), GNGBY (Ginkgo Bioworks Holdings Inc), and KYKOF (Kyokuto Pharmaceutical Ind). Sonic Healthcare's comprehensive service offerings and international presence position it to capitalize on the increasing demand for diagnostic services.
Who Are SKHCF's Key Customers?
- Medical practitioners who require diagnostic testing for their patients.
- Hospitals that outsource their laboratory and radiology services.
- Community health services needing diagnostic support.
- Employers seeking occupational health services for their employees.
- Patients requiring primary care medical services.
ROE 6%Key Financial Metrics
Return on equity for Sonic Healthcare Limited stands at 6.4%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 3.2%, showing how much profit it generates from its asset base. SKHCF trades at a trailing price-to-earnings ratio of 19.16, below the Healthcare sector average of ~23x. Its free cash flow yield is 8.4%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.01 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 5.2%, the inverse of the P/E and a quick read on earnings relative to price.
Sonic Healthcare Limited (SKHCF) Valuation Context
Valued at $6.31B, SKHCF is classified as a mid-cap stock.
Company Profile
Sonic Healthcare Limited operates in the Medical - Diagnostics & Research industry within the Healthcare sector. It is headquartered in Sydney, AU. The company is led by CEO James Pacey Newcombe. SKHCF has traded publicly since 2010.
F-Score 6/9Financial Health
Sonic Healthcare Limited's Piotroski F-Score is 6/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 2.47 places it in the grey zone, a middle ground that warrants monitoring.
FY2026 estForward Outlook
Wall Street analysts project Sonic Healthcare Limited revenue of about $10.97B for fiscal 2026, with EPS near $1.23. The estimate reflects 16 contributing analysts.
SKHCF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Sonic Healthcare has seen positive insider buying, indicating confidence from management in the company's future prospects.
- Recent community sentiment has shifted positively, with discussions highlighting the resilience of healthcare services amidst economic fluctuations.
- The company has expanded its testing capabilities, which is seen as a strategic move to capture more market share in a growing healthcare sector.
- Market perception is buoyed by the ongoing demand for diagnostic services, underscoring Sonic's essential role in public health.
Bear Case
- Some analysts express concern over potential regulatory changes that could impact operational efficiency and profitability.
- Community sentiment has also shown some skepticism regarding the company's ability to maintain growth in a competitive landscape.
- Recent discussions point to rising costs in labor and materials, which could pressure margins and affect earnings.
- There are worries about over-reliance on specific testing services, which may limit diversification and expose the company to market vulnerabilities.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
SKHCF Latest News
No recent news available for SKHCF.
SKHCF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for SKHCF.
Price Targets
Wall Street price target analysis for SKHCF.
SKHCF MoonshotScore
What does this score mean?
The MoonshotScore rates SKHCF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: James Pacey Newcombe
Managing Director and Chief Executive Officer
James Pacey Newcombe serves as the Managing Director and Chief Executive Officer of Sonic Healthcare Limited. His leadership role involves overseeing the operations of a large organization with approximately 42,000 employees. Information regarding his specific educational background and previous roles is not available in the provided data. However, his current position indicates a significant level of experience and expertise in the healthcare industry.
Track Record: Due to limited information, specific achievements and milestones under James Pacey Newcombe's leadership cannot be detailed. However, leading a company of Sonic Healthcare's size and scope suggests a track record of strategic decision-making and operational management. Further research would be needed to fully assess his impact on the company's performance and growth.
SKHCF OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Sonic Healthcare Limited (SKHCF) may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited or no financial disclosure, making it difficult for investors to assess their financial health and operational performance. Investing in OTC Other stocks carries a higher degree of risk compared to stocks listed on major exchanges like the NYSE or NASDAQ due to the lack of regulatory oversight and transparency.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure makes it difficult to assess the company's financial health.
- Lower trading volume can lead to price volatility and difficulties in buying or selling shares.
- Lack of regulatory oversight increases the risk of fraud and manipulation.
- Potential for delisting or suspension of trading due to non-compliance with OTC market rules.
- Higher bid-ask spreads can increase transaction costs for investors.
- Verify the company's registration and compliance with regulatory requirements.
- Review any available financial statements and disclosures.
- Assess the company's business model and competitive landscape.
- Research the company's management team and their track record.
- Monitor trading volume and price movements for signs of manipulation.
- Understand the risks associated with investing in OTC stocks.
- Consult with a financial advisor before making any investment decisions.
- Established history of operations since 1934.
- Global presence in multiple countries.
- Comprehensive range of diagnostic services.
- Partnerships with reputable healthcare providers.
- Compliance with relevant healthcare regulations and standards.
What Investors Ask About Sonic Healthcare Limited (SKHCF) — Healthcare
What does Sonic Healthcare Limited do?
Sonic Healthcare Limited is a global medical diagnostics company providing a comprehensive range of laboratory and radiology services to medical practitioners, hospitals, and community health services. The company's services include pathology testing, such as biochemistry, genetics, and microbiology, as well as radiology services like MRI, CT scans, and X-rays. Sonic Healthcare operates in multiple countries, including Australia, the United Kingdom, and the United States, offering a broad spectrum of diagnostic solutions to support patient care and healthcare decision-making.
What are the main risks for SKHCF?
The main risks for Sonic Healthcare Limited include changes in healthcare regulations and reimbursement policies, which could negatively impact revenue. Increased competition from other diagnostic service providers could erode market share. Technological obsolescence could render existing diagnostic equipment and services obsolete. Economic downturns could reduce demand for diagnostic testing. Additionally, errors in diagnostic testing could lead to liability claims and reputational damage, impacting the company's financial performance and market position.
What are the key factors to evaluate for SKHCF?
Evaluate SKHCF on fundamentals, analyst consensus, and risk factors. Not financial advice.
How frequently does SKHCF data refresh on this page?
SKHCF prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven SKHCF's recent stock price performance?
Sonic Healthcare Limited (SKHCF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Comprehensive range of diagnostic services. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider SKHCF overvalued or undervalued right now?
Valuing Sonic Healthcare Limited (SKHCF) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying SKHCF?
Before investing in Sonic Healthcare Limited (SKHCF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Why might investors consider adding SKHCF to a portfolio?
Key strength of Sonic Healthcare Limited (SKHCF): Comprehensive range of diagnostic services. Weigh rewards against risks and diversify. Not financial advice.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based on available data and may be subject to change.
- AI analysis is pending for SKHCF.